TY - JOUR
T1 - Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis
T2 - A 17-Year update
AU - Silbermann, Elizabeth
AU - Senders, Angela
AU - Wooliscroft, Lindsey
AU - Rice, Jessica
AU - Cameron, Michelle
AU - Waslo, Carin
AU - Orban, Anna
AU - Chase, Emma
AU - Yadav, Vijayshree
AU - Bourdette, Dennis
AU - Spain, Rebecca I.
N1 - Funding Information:
Silbermann is supported by NMSS Sylvia Lawry Fellowship.
Funding Information:
This work was supported by the National Multiple Sclerosis Society [R-1705-27,628] and the Oregon Clinical and Translational Research Institute [UL1 RR024140 from the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health ]; the content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/6
Y1 - 2020/6
N2 - Background: In 2001, we conducted a survey on use of complementary and alternative medicine (CAM) in people with multiple sclerosis (pwMS) in Oregon and Southwest Washington to treat their disease. Objectives, Methods: In 2018, we administered a revised survey in the same region to describe updated patterns of CAM use in pwMS and to compare changes in use, perceived benefit, and patterns of communication between participants and providers regarding CAM over the past 17 years. Results: 81% of respondents in 2018 (n = 1014) used a CAM supplement (vitamins, minerals, herbs), 39% used mind-body therapies (mindfulness, massage), 41% used specific diet, and 81% used exercise to treat their multiple sclerosis. Since 2001, use of supplements, exercise, and mind-body therapies have increased (65% to 81%, 67 to 81%, and 14% to 39%). Participants were also nine times more likely to speak to their neurologists about CAM use (6.7% to 55.4%). In 2018, factors associated with CAM use included female sex, progressive disease, and longer time since multiple sclerosis diagnosis. Conclusion: These findings highlight the high and increasing prevalence of CAM use in pwMS and factors associated with CAM use, and underscore the importance of research to investigate safety and efficacy of these therapies.
AB - Background: In 2001, we conducted a survey on use of complementary and alternative medicine (CAM) in people with multiple sclerosis (pwMS) in Oregon and Southwest Washington to treat their disease. Objectives, Methods: In 2018, we administered a revised survey in the same region to describe updated patterns of CAM use in pwMS and to compare changes in use, perceived benefit, and patterns of communication between participants and providers regarding CAM over the past 17 years. Results: 81% of respondents in 2018 (n = 1014) used a CAM supplement (vitamins, minerals, herbs), 39% used mind-body therapies (mindfulness, massage), 41% used specific diet, and 81% used exercise to treat their multiple sclerosis. Since 2001, use of supplements, exercise, and mind-body therapies have increased (65% to 81%, 67 to 81%, and 14% to 39%). Participants were also nine times more likely to speak to their neurologists about CAM use (6.7% to 55.4%). In 2018, factors associated with CAM use included female sex, progressive disease, and longer time since multiple sclerosis diagnosis. Conclusion: These findings highlight the high and increasing prevalence of CAM use in pwMS and factors associated with CAM use, and underscore the importance of research to investigate safety and efficacy of these therapies.
KW - Complementary therapies
KW - Health survey
KW - Multiple sclerosis
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85082194563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082194563&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2020.102041
DO - 10.1016/j.msard.2020.102041
M3 - Article
C2 - 32200340
AN - SCOPUS:85082194563
SN - 2211-0348
VL - 41
JO - Multiple sclerosis and related disorders
JF - Multiple sclerosis and related disorders
M1 - 102041
ER -